Trial Identifiers
Use the hyperlinks, where available to access additional clinical trial information.
Trial sponsor
Melanoma and Skin Cancer Trials Limited
Scientific Title
A Phase Ib/II Study of Combination Avelumab With Peptide Receptor Radionuclide Therapy or Conventional Fractionated Radiotherapy in Patients With Metastatic Merkel Cell Carcinoma